NCT03953703View on ClinicalTrials.gov

Levocarnitine for Dry Eye in Sjogren's Syndrome

PHASE2Active, not recruitingINTERVENTIONAL

Enrollment

15

Participants

Timeline

Start Date

November 17, 2021

Primary Completion Date

November 1, 2025

Study Completion Date

December 31, 2025

Conditions

Sjogren's SyndromeKeratoconjunctivitis Sicca

Interventions

DRUG

Levocarnitine

Levocarnitine 1000 mg twice per day for 6 weeks

DRUG

Placebo

Placebo 1000 mg twice per day for 6 weeks

Trial Locations (1)

37232

Vanderbilt University Medical Center, Nashville

All Listed Sponsors

lead

Vanderbilt University Medical Center

OTHER